Eventide Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,970,000
| Closed | -$13.9M | – | 154 |
|
|
2023
Q3 | $13.9M | Hold |
1,970,000
| – | – | 0.25% | 105 |
|
|
2023
Q2 | $13.9M | Buy |
1,970,000
+867,111
| +79% | +$6.1M | 0.23% | 107 |
|
|
2023
Q1 | $9.2M | Buy |
+1,102,889
| New | +$9.2M | 0.17% | 118 |
|
|
2019
Q1 | – | Sell |
-1,047,000
| Closed | -$8.45M | – | 132 |
|
|
2018
Q4 | $8.45M | Hold |
1,047,000
| – | – | 0.37% | 72 |
|
|
2018
Q3 | $7.99M | Buy |
+1,047,000
| New | +$7.99M | 0.29% | 86 |
|
|
2018
Q1 | – | Sell |
-290,000
| Closed | -$1.42M | – | 145 |
|
|
2017
Q4 | $1.42M | Hold |
290,000
| – | – | 0.07% | 117 |
|
|
2017
Q3 | $1.52M | Hold |
290,000
| – | – | 0.09% | 111 |
|
|
2017
Q2 | $1.61M | Buy |
+290,000
| New | +$1.61M | 0.1% | 101 |
|